These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies. Volkmann ER; Tashkin DP Ann Am Thorac Soc; 2016 Nov; 13(11):2045-2056. PubMed ID: 27560196 [TBL] [Abstract][Full Text] [Related]
32. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group. Pope J; Harding S; Khimdas S; Bonner A; ; Baron M J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347 [TBL] [Abstract][Full Text] [Related]
33. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660 [TBL] [Abstract][Full Text] [Related]
34. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Strand V Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222 [No Abstract] [Full Text] [Related]
36. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts. Walker KM; Pope J; ; Semin Arthritis Rheum; 2012 Aug; 42(1):42-55. PubMed ID: 22464314 [TBL] [Abstract][Full Text] [Related]
37. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241 [TBL] [Abstract][Full Text] [Related]
38. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Strange G; Nash P Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346 [TBL] [Abstract][Full Text] [Related]
39. Localized and systemic scleroderma. Hawk A; English JC Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134 [TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring? Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]